Authors
Loading...
Systematic review reveals sparse evidence and high heterogeneity among drug trials in adults with autism spectrum disorder, highlighting the urgent need for standardized large-scale studies.
Miguel et al. (2023) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: